BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:985. [DOI: 10.3390/biomedicines10050985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Maher R, Moreno-borrallo A, Jindal D, Mai BT, Ruiz-hernandez E, Harkin A. Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery. Pharmaceutics 2023;15:746. [DOI: 10.3390/pharmaceutics15030746] [Reference Citation Analysis]
2 Yagolovich AV, Gasparian ME, Dolgikh DA. Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway. Pharmaceutics 2023;15. [PMID: 36839837 DOI: 10.3390/pharmaceutics15020515] [Reference Citation Analysis]
3 Patel D, Patel B, Wairkar S. Intranasal delivery of biotechnology-based therapeutics. Drug Discov Today 2022;:103371. [PMID: 36174965 DOI: 10.1016/j.drudis.2022.103371] [Reference Citation Analysis]